NeuClone Starts Trial For Ustekinumab Biosimilar
NeuLara Rival To Stelara Enters Phase I Clinical Trial
Executive Summary
After extensive pre-clinical testing, NeuClone has commenced dosing in a Phase I clinical trial for its Stelara biosimilar candidate, NeuLara.